The posting
Job description
The Senior Director, Market Access & Pricing, Europe is responsible for leading Taiho Oncology Europe's market access, pricing and reimbursement strategy across European markets. As the senior Market Access leader for the region, this role will shape access, pricing and value strategies across the portfolio, ensuring that payer, HTA and reimbursement considerations are integrated into development, launch and lifecycle decisions. The role serves as a key strategic advisor to the European leadership team and partners closely with global and regional stakeholders to support sustainable patient access and maximize portfolio value. In a growing organization, the successful candidate will combine strategic leadership with a pragmatic, hands-on approach and play a key role in building Taiho’s presence and organization across Europe.
- Advanced degree in Life Sciences, Health Economics, Business, Pharmacy, Public Health or a related discipline preferred.
- Significant pharmaceutical or biotechnology industry experience in Market Access, Pricing & Reimbursement and/or HEOR.
- Proven success developing and implementing market access and pricing strategies across multiple European markets.
- Demonstrated experience supporting European product launches, including launch sequencing, pricing and reimbursement strategy and market access readiness.
- Deep understanding of European healthcare systems, HTA processes, reimbursement pathways and payer decision-making.
- Strong knowledge of international reference pricing, launch sequencing and European pricing dynamics.
- Experience in leading pan-European market access functions preferred.
- Significant experience supporting oncology products, including engagement with oncology-specific HTA and reimbursement processes.
- Experience engaging with payers, HTA agencies and external stakeholders.
- Demonstrated ability to lead complex cross-functional initiatives within a regional or global environment.
- Fluent English required; additional European languages are an advantage.
Success Measures
- Successful market access preparation and execution for European launches and new indications.
- Achievement of key reimbursement and patient access milestones across priority markets.
- Development and implementation of a sustainable European pricing strategy.
- Establishment of fit-for-purpose Market Access capabilities, governance and processes.
- Strong cross-functional leadership and contribution to the development of Taiho Oncology Europe.
Key Competencies
- Strategic thinker with strong commercial and business acumen.
- Combines strategic thinking with a pragmatic, hands-on approach.
- Deep expertise in European market access, pricing and reimbursement.
- Strong leadership and influencing skills in matrix organizations.
- Ability to translate complex access challenges into practical business recommendations.
- High level of ownership, accountability and execution focus.
- Highly collaborative leader who actively seeks diverse perspectives, leverages team strengths and fosters a culture of shared accountability and collective achievement.
- Thrives in a dynamic, entrepreneurial and evolving environment.
- Acts with the highest ethical and professional standards.
Strategic Leadership
- Lead the development and execution of European market access, pricing and reimbursement strategies for Taiho's portfolio.
- Provide strategic guidance to European leadership on market access opportunities, risks and value optimization.
- Ensure payer, HTA and pricing considerations are incorporated into portfolio, launch and lifecycle planning.
- Monitor changes in the European access environment and evaluate implications for Taiho's business.
- Build and develop Market Access capabilities as the European organization evolves, including leading internal team members and external partners as appropriate.
Pricing, Reimbursement & Market Access
- Develop European pricing strategies and provide oversight of pricing and reimbursement decisions across markets.
- Assess the impact of international and external reference pricing (IRP/ERP), launch sequencing, price corridors, most-favored-nation (MFN) considerations and cross-market pricing interdependencies.
- Support reimbursement negotiations, pricing governance and market access planning across Europe.
- Evaluate innovative access models and agreements that support both patient access and sustainable value.
HTA, Evidence & Value Strategy
- Provide strategic direction on HTA, value demonstration and payer evidence requirements.
- Partner with Medical Affairs and global functions to develop value propositions, evidence strategies and payer materials.
- Ensure European payer perspectives are reflected in development, launch and lifecycle decisions.
Launch Readiness & Execution
- Lead market access activities supporting European product launches and new indications.
- Support country teams and external partners in the execution of local market access and reimbursement strategies.
- Provide direct market access expertise in markets where dedicated local capabilities do not exist.
Stakeholder Engagement & Organizational Leadership
- Represent Taiho with relevant payers, HTA bodies, industry groups and other market access stakeholders, where appropriate.
- Partner closely with Medical Affairs, Commercial, Regulatory, HEOR, Finance and Global Market Access to align integrated product strategies.
- Serve as the regional authority on market access and pricing strategy, providing recommendations and governance oversight for pricing and reimbursement decisions.
- Lead cross-functional initiatives and contribute to the development of European market access capabilities, processes and operating models.
- Manage Market Access budgets, external agencies, HEOR vendors and strategic consulting partners to ensure efficient delivery of business objectives.
- Partner in building Taiho’s European organization, culture and ways of working, contributing actively as a member of the European leadership team.
